Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2118 of 5804
-
Desperate patients get early access to promising new drug
Disease control AVAILABLEProvide pre-approval single patient expanded access of retatrutide for patients.
Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Lifeline for kids with severe epilepsy: drug access extended
Disease control AVAILABLEThis is an extended access study for participants who have completed Rufinamide Study E2080-G000-303 to continue to have access to rufinamide until it becomes commercially available in Poland or until no participants remain in the EAP.
Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Experimental device aims to tame disease without drugs
Disease control WITHHELDSponsor: [Redacted] • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Last-Resort access to dupilumab for patients with severe inflammation
Disease control APPROVED_FOR_MARKETINGProvide Compassionate Use of Dupilumab
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Second chance: yescarta offered to lymphoma patients despite manufacturing hiccups
Disease control AVAILABLEThe goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel, that is otherwise out of specification for commercial release.
Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for SCA patients: expanded access to investigational drug troriluzole
Disease control AVAILABLEThe purpose of this expanded access protocol is to provide access to the investigational drug troriluzole in patients with spinocerebellar ataxia (SCA).
Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for leukemia patients allergic to key chemo drug
Disease control NO_LONGER_AVAILABLEThe purpose of this study is to make Erwinase available to patients with acute lymphoblastic leukemia (ALL) who have had previous allergic reactions to certain formulations of L-asparaginase.
Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Last-Resort cancer drug made available to patients with no alternatives
Disease control NO_LONGER_AVAILABLEThe expanded access program allows people to gain access to an unlicensed treatment on compassionate grounds. This expanded access program provides adults with refractory metastatic colorectal cancer (mCRC) and who cannot neither adequately be treated by current standard of care …
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New stem cell filter could make transplants safer for vulnerable patients
Disease control AVAILABLEAllogeneic stem cell transplantation (alloSCT) is utilized for various underlying diseases. AlloSCT is limited by graft versus host disease (GVHD), graft rejection, viral infections, and post-transplant lymphoproliferative disorders. To mitigate graft versus host disease, graft m…
Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Last-Resort drug access opens for rare sly syndrome patients
Disease control AVAILABLEIndividual patient expanded access requests may be considered for patients who have no other treatment options
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Desperate patients get access to experimental Lab-Made vessel
Disease control TEMPORARILY_NOT_AVAILABLEIndividual patient expanded access requests may be considered for patients who have no other treatment options and are not eligible for an ATEV clinical study.
Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC
-
New scan spots tiny pancreatic tumors that cause dangerous low blood sugar
Diagnosis AVAILABLEThis purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET (Positron Emission Tomography) scan to detect a focal lesion of hyperinsulinism and determine the location in patients with congenital hyperinsulinism, Beckwith Wiedema…
Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
New hope for catheter patients: expanded access to Infection-Fighting drug DefenCath
Prevention NO_LONGER_AVAILABLEThe EAP for DefenCath is designed to provide access to a broader population of adult and pediatric patients using catheters for various serious medical conditions. A key aspect of this EAP is its focus on individuals who, due to their unique clinical circumstances, are either ine…
Sponsor: CorMedix • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Ultra-Fast radiation zaps skin cancer in new pilot trial
Disease control Not yet recruitingThe primary purpose of this research trial is to study the safety of electron FLASH treatment for cutaneous lymphoma lesions. In addition, investigators will confirm the accuracy of dose and dose rate delivery of electron FLASH therapy using on-patient dosimetry measurements in c…
Phase: NA • Sponsor: Lesley A. Jarvis • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
AI and community health workers team up to help diabetes patients after hospital stays
Disease control Not yet recruitingThis study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medications after leaving the hospital. Many patients with diabetes take multiple medications, and changes to these medications d…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Weeding out stress: gardening program aims to boost cancer Survivors' Well-Being
Symptom relief Not yet recruitingThis study is testing whether a gardening and nutrition program can improve well-being in people who have had cancer. Many cancer survivors continue to experience challenges after treatment, including changes in appetite, nutrition, stress, and quality of life. Programs that comb…
Phase: NA • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New study tailors Reward-Based therapy to help black adults overcome stimulant addiction
Disease control Not yet recruitingThe purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Sound therapy offers hope for empty nose sufferers
Symptom relief Not yet recruitingThis study is to determine whether Acoustic Resonance Therapy (ART), an FDA-approved treatment for standard nasal obstruction, may be helpful in mitigating the debilitating symptoms of Empty Nose Syndrome (ENS), which includes an alternative form of nasal obstruction. ART is a no…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Ancient gut therapy takes on allergies in new clinical trial
Disease control Not yet recruitingBackground Allergic Rhinitis is a chronic Th2-mediated inflammatory disorder associated with significant disease burden and impaired quality of life. Emerging evidence highlights the role of the gut-immune axis, intestinal permeability, and microbial-metabolic signaling in modula…
Phase: NA • Sponsor: Amrita Vishwa Vidyapeetham • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Shockingly simple: wearable zaps aim to end bladder leaks for paralyzed men
Symptom relief Not yet recruitingUrinary incontinence, bladder frequency, and bladder urgency are significant medical problems for people with overactive bladder (OAB) or neurogenic bladder overactivity (NDO). Affected individuals typically experience reflex bladder contractions in response to bladder filling at…
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC